Sec Form 3 Filing - Curnes Nelson Bunker @ Mobia Medical, Inc. - 2026-05-07

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Curnes Nelson Bunker 2. Issuer Name and Ticker or Trading Symbol Mobia Medical, Inc. [ MOBI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) 2802 FLINTROCK TRACE, SUITE 226 3. Date of Earliest Transaction (MM/DD/YY) 05/07/2026 (Street) AUSTIN, TX78738 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 19,427 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 54,932 D Series C Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 28,710 D Series D Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 110,058 D Series E-1 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 8,374 D Series F Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 81,821 D Series C Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 2,871 I By Bridget Kelley Curnes Trust Series C Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 2,871 I By Evelyn Christine Curnes Trust Series D Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 145,067 I By Exceller Hunt Microtransponder 2017, LP Series E-1 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 78,171 I By Exceller Hunt Microtransponder 2017, LP Series E-2 Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 171,179 I By Exceller Hunt Microtransponder 2017, LP Series F Preferred Stock ( 1 ) ( 1 ) ( 1 ) Common Stock 82,068 I By Exceller Hunt Microtransponder 2017, LP Warrants $ 14.653 ( 2 ) 06/13/2033 Common Stock 6,890 D Warrants $ 14.653 ( 2 ) 05/24/2033 Common Stock 6,794 D Convertible Notes ( 3 ) ( 3 ) ( 3 ) Common Stock 175,077 I By Curnes Fund 2001 Convertible Notes ( 3 ) ( 3 ) ( 3 ) Common Stock 333,333 I By Exceller Hunt Microtransponder 2017, LP Stock Option $ 3.73 ( 4 ) 12/14/2027 Common Stock 103,359 D Stock Option $ 4.11 ( 5 ) 03/26/2030 Common Stock 38,553 D Stock Option $ 4.11 ( 6 ) 03/26/2030 Common Stock 42,708 D Stock Option $ 3.94 ( 7 ) 10/16/2035 Common Stock 34,037 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Curnes Nelson Bunker 2802 FLINTROCK TRACE, SUITE 226 AUSTIN, TX78738 Chief Financial Officer Signatures /s/ Chase Leavitt, Attorney-in-Fact 05/07/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Each share of our Series A, Series C, Series D, Series E-1, Series E-2 and Series F Preferred Stock will convert into Common Stock immediately prior to the completion of the Issuer's initial public offering pursuant to its terms. ( 2 )The warrants are currently exercsisable. In connection with the Issuer's initial public offering (the "Offering"), the warrants will be exercised according to the terms of the applicable warrant agreement. The warrants have a net exercise provision under which the Reporting Person may, in lieu of payment of the exercise price in cash, surrender the warrants and receive a net amount of shares based on the fair market value of the shares at the time of exercise of the warrants after deduction of the aggregate exercise price. ( 3 )The Convertible Notes will automatically convert into Common Stock immediately prior to the closing of the Offering. The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes. ( 4 )The stock option is fully vested and exercisable. ( 5 )The stock option vested as to 25% of the underlying shares on March 11, 2025, and will vest thereafter in 36 substantially equal monthly installments. ( 6 )The stock option vested as to 25% of the underlying shares on March 5, 2026, and will vest thereafter in 36 substantially equal monthly installments. ( 7 )The stock option will vest as to 25% of the underlying shares on October 17, 2026, and will vest thereafter in 36 substantially equal monthly installments.

Remarks: Exhibit 24 - Power of Attorney.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.